21789 views | 7 years ago
Access the full presentations here: http://www.illumina.com/lisbon-lectures Learn how these European cancer researchers are leveraging the power of genomics to gain deeper insights and advance ImmunoOncology...
940 views | 7 years ago
Access the full presentations here: http://www.illumina.com/lisbon-lectures Learn how these European cancer researchers are leveraging the power of genomics to gain deeper insights and advance ImmunoOncology...
18887 views | 7 years ago
Access the full presentations here: http://www.illumina.com/lisbon-lectures Learn how these European cancer researchers are leveraging the power of genomics to gain deeper insights and advance ImmunoOncology...
8155 views | 7 years ago
In this recorded webinar, Glenn Palomaki, PhD, discusses the clinical validity and utility of offering noninvasive prenatal testing (NIPT), also known as cell-free DNA screening, as a primary screen...
5000 views | 7 years ago
Dr Torsten Haferlach of Munich Leukemia Laboratory (MLL) discusses their goal to sequence, by whole genome sequencing, 5,000 patients with different kinds of leukemias and lymphomas—ultimately understanding...
1087 views | 7 years ago
Illumina has developed an extensive service network to empower scientists around the world with next-generation sequencing (NGS). http://www.Illumina.com/support Our global, multi-lingual team includes...
1950 views | 7 years ago
Career journey in a word: Growing Lei Tong came to Illumina in 2011 as a technical applications scientist. In her current role as Manager, Technical Support, Lei Tong leads a team that provides technical...
1669 views | 7 years ago
Career journey in a word: Extraordinary Seng Keat joined Illumina in July 2013 as a senior research associate. In this role, he was involved in the early development and integration of the NextSeq 500...